BioLife Solutions, Inc.
BLFS
$25.41
-$1.09-4.11%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 74.01M | 67.33M | 61.62M | 56.12M | 53.40M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 74.01M | 67.33M | 61.62M | 56.12M | 53.40M |
| Cost of Revenue | 15.59M | 12.85M | 10.37M | 8.41M | 5.03M |
| Gross Profit | 58.41M | 54.48M | 51.26M | 47.71M | 48.37M |
| SG&A Expenses | 48.63M | 45.86M | 43.53M | 42.20M | 42.08M |
| Depreciation & Amortization | 2.11M | 2.10M | 2.07M | 2.06M | 1.44M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 75.05M | 68.70M | 63.18M | 59.75M | 55.85M |
| Operating Income | -1.04M | -1.37M | -1.56M | -3.63M | -2.45M |
| Income Before Tax | -13.90M | -15.15M | -5.00M | -7.75M | 2.07M |
| Income Tax Expenses | 91.00K | -71.00K | -196.00K | -193.00K | -295.00K |
| Earnings from Continuing Operations | -13.99 | -15.08 | -4.81 | -7.56 | 2.37 |
| Earnings from Discontinued Operations | 10.79M | 9.55M | -5.61M | -12.63M | -49.97M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.21M | -5.53M | -10.41M | -20.18M | -47.60M |
| EBIT | -1.04M | -1.37M | -1.56M | -3.63M | -2.45M |
| EBITDA | 4.43M | 5.08M | 5.88M | 4.70M | 6.89M |
| EPS Basic | -0.06 | -0.11 | -0.23 | -0.45 | -1.05 |
| Normalized Basic EPS | 0.02 | 0.00 | -0.01 | -0.05 | -0.03 |
| EPS Diluted | -0.07 | -0.12 | -0.24 | -0.46 | -1.05 |
| Normalized Diluted EPS | 0.02 | 0.00 | -0.01 | -0.05 | -0.03 |
| Average Basic Shares Outstanding | 189.51M | 187.76M | 185.96M | 184.26M | 182.43M |
| Average Diluted Shares Outstanding | 191.69M | 189.14M | 187.35M | 185.64M | 182.43M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |